Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2491
    -0.0020 (-0.16%)
     
  • Bitcoin GBP

    51,226.41
    -524.52 (-1.01%)
     
  • CMC Crypto 200

    1,333.04
    -63.49 (-4.55%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Why Teladoc Health Fell by 6.6% Today

Why Teladoc Health Fell by 6.6% Today

Shares of Teladoc Health (NYSE: TDOC) were a bit sickly on Monday after one of the more prominent analysts tracking the stock knocked his target price down. Truist Securities' Sandy Draper, who has closely followed the fortunes of Teladoc throughout the coronavirus pandemic, was the prognosticator shaving his price target. The change comes not long after Teladoc reported its first-quarter results.